ADC THERAPEUTICS SA shareholders Q3 2023

ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 41 filers reported holding ADC THERAPEUTICS SA in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.1%.

ADC THERAPEUTICS SA shareholders Q3 2023
NameSharesValueWeighting ↓
Prosight Management, LP 5,402,041$4,845,6311.54%
Sio Capital Management, LLC 3,294,534$2,955,1970.92%
Redmile Group, LLC 14,178,045$12,717,7060.60%
AlphaCentric Advisors LLC 1,068,468$958,4160.54%
Vantage Consulting Group Inc 850,737$763,1110.51%
Blue Owl Capital Holdings LP 733,568$654,4890.51%
Affinity Asset Advisors, LLC 1,100,000$986,7000.28%
Frazier Life Sciences Management, L.P. 1,647,030$1,477,3860.10%
Indie Asset Partners, LLC 92,700$83,1520.08%
GCM Grosvenor Holdings, LLC 410,888$368,5670.07%
Nantahala Capital Management 257,162$230,6740.02%
ELCO Management Co., LLC 21,532$19,3140.01%
XTX Topco Ltd 67,051$60,1450.01%
GSA CAPITAL PARTNERS LLP 121,897$1090.01%
Hennion & Walsh Asset Management, Inc. 57,867$51,9070.00%
Miracle Mile Advisors, LLC 84,496$75,7930.00%
Citadel Advisors 2,898,121$2,599,6140.00%
Magnetar Financial LLC 55,762$50,0190.00%
ACADIAN ASSET MANAGEMENT LLC 156,048$1380.00%
Gladius Capital Management LP 19,752$17,7180.00%
External links

This page lists ADC THERAPEUTICS SA's shareholders in Q3 2023. To view ADC THERAPEUTICS SA's shareholder history, click here.